These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19372019)

  • 1. The risks of changing the rules for previously validated biomarkers and using the same patients several times. Response letter to Calès et al. Gastroenterol Clin Biol 2008;32:1050-60: "Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests".
    Munteanu M; Ngo Y; Ratziu V; Poynard T
    Gastroenterol Clin Biol; 2009 May; 33(5):387-8; author reply 388-9. PubMed ID: 19372019
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests.
    Calès P; Boursier J; de Lédinghen V; Halfon P; Bacq Y; Leroy V; Dib N; Oberti F; Sawadogo A; Rousselet MC; Lunel F
    Gastroenterol Clin Biol; 2008 Dec; 32(12):1050-60. PubMed ID: 19019606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FibroMeters: a family of blood tests for liver fibrosis.
    Calès P; Boursier J; Oberti F; Hubert I; Gallois Y; Rousselet MC; Dib N; Moal V; Macchi L; Chevailler A; Michalak S; Hunault G; Chaigneau J; Sawadogo A; Lunel F
    Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):40-51. PubMed ID: 18973845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Other non-invasive markers of liver fibrosis.
    Leroy V
    Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):52-7. PubMed ID: 18973846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of blood panel markers in the diagnosis of hepatic fibrosis].
    Zeng MD; Mao YM; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):163-5. PubMed ID: 18364067
    [No Abstract]   [Full Text] [Related]  

  • 6. [Non-invasive diagnosis of liver fibrosis: guidelines for the use of biomarkers and FibroScan].
    Vergniol J; de Ledinghen V
    Gastroenterol Clin Biol; 2009 Apr; 33(4):334-44. PubMed ID: 19346090
    [No Abstract]   [Full Text] [Related]  

  • 7. Proteomic approaches in the search for biomarkers of liver fibrosis.
    Cowan ML; Rahman TM; Krishna S
    Trends Mol Med; 2010 Apr; 16(4):171-83. PubMed ID: 20304704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of liver fibrosis in clinical practice].
    Abenavoli L; Leggio L; Gasbarrini G; Addolorato G
    Recenti Prog Med; 2006 Sep; 97(9):481-5. PubMed ID: 17017301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.
    Munteanu M; Ratziu V; Morra R; Messous D; Imbert-Bismut F; Poynard T
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):187-91. PubMed ID: 18568141
    [No Abstract]   [Full Text] [Related]  

  • 10. Noninvasive biochemical markers of liver fibrosis.
    Grigorescu M
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):149-59. PubMed ID: 16802010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serologic diagnosis of liver fibrosis].
    Sauerbruch T
    Dtsch Med Wochenschr; 1999 Oct; 124(41):1191. PubMed ID: 10572514
    [No Abstract]   [Full Text] [Related]  

  • 12. Towards the non-invasive diagnosis of cirrhosis: the nuts-cirrhosis connection.
    Bosch J
    J Hepatol; 2009 Jan; 50(1):4-6. PubMed ID: 19019481
    [No Abstract]   [Full Text] [Related]  

  • 13. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
    Lee KG; Seo YS; An H; Um SH; Jung ES; Keum B; Yim HJ; Jeen YT; Chun HJ; Kim CD; Ryu HS
    J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FibroTest-ActiTest as a non-invasive marker of liver fibrosis.
    Halfon P; Munteanu M; Poynard T
    Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):22-39. PubMed ID: 18973844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time?
    Thuluvath PJ; Krok KL
    Am J Gastroenterol; 2006 Jul; 101(7):1497-9. PubMed ID: 16863552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.
    Corpechot C; Poujol-Robert A; Wendum D; Galotte M; Chrétien Y; Poupon RE; Poupon R
    Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of FibroIndex.
    Halfon P; Penaranda G; Renou C; Bourliere M
    Hepatology; 2007 Jul; 46(1):280-1; author reply 281-2. PubMed ID: 17596884
    [No Abstract]   [Full Text] [Related]  

  • 18. Re. Zuckerman et al.--Sensitivity of CA-125 in patients with liver cirrhosis in the presence of ascites.
    Sari R; Yildirim B; Sevinc A; Hilmioglu F
    Am J Gastroenterol; 2001 Jan; 96(1):253-4. PubMed ID: 11197269
    [No Abstract]   [Full Text] [Related]  

  • 19. The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis.
    Boursier J; Vergniol J; Sawadogo A; Dakka T; Michalak S; Gallois Y; Le Tallec V; Oberti F; Fouchard-Hubert I; Dib N; Rousselet MC; Konaté A; Amrani N; de Ledinghen V; Calès P
    Liver Int; 2009 Nov; 29(10):1507-15. PubMed ID: 19725892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility of non-invasive fibrosis biomarkers, FibroMeter and FibroTest, could be improved by respecting the analytical standardizations.
    Munteanu M; Imbert-Bismut F; Messous D; Morra R; Thabut D; Lebray P; Benhamou Y; Ratziu V; Poynard T
    Clin Biochem; 2008 Sep; 41(13):1113-4. PubMed ID: 18486610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.